Neratinib and Capecitabine for Patients with HER2+ Breast Cancer Brain Metastases (BCBM)

moasc has 207 videos Subscribe Here

Description: Daniela Bota, MD of UC Irvine Health discusses the use of neratinib and capecitabine in patients with breast cancer brain metastases at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.

Abstract 1005: TBCRC 022: Phase II Trial of Neratinib + Capecitabine for Patients (pts) with Human Epidermal Growth Factor Receptor 2 (HER2+) Breast Cancer Brain Metastases (BCBM)
Shared By : moasc
Posted on : 08/03/17
Added : 4 months ago
Category : Breast Cancer


Nothing found.

More From moasc

Nothing found.